ITK and RLK inhibitor improves skin disease in a psoriatic mouse model

被引:0
|
作者
Fuhriman, J. M. [1 ]
Winge, M. C. G. [1 ]
Haberstock-Debic, H. [2 ]
Funk, J. Oliver [2 ]
Bradshaw, M. [2 ]
Marinkovich, M. [3 ]
机构
[1] Stanford Univ, Stanford, CA 94305 USA
[2] Principia Biopharma Inc, San Francisco, CA USA
[3] Stanford Univ, Sch Med, Stanford, CA 94305 USA
关键词
D O I
10.1016/j.jid.2017.02.723
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
700
引用
收藏
页码:S120 / S120
页数:1
相关论文
共 50 条
  • [1] ITK and RLK Inhibitor PRN694 Improves Skin Disease in Two Mouse Models of Psoriasis
    Fuhriman, Jessica M.
    Winge, Marten C. G.
    Haberstock-Debic, Helena
    Funk, Jens Oliver
    Bradshaw, J. Michael
    Marinkovich, M. Peter
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2018, 138 (04) : 864 - 871
  • [2] A Small Molecule Inhibitor of ITK and RLK Impairs Th1 Differentiation and Prevents Colitis Disease Progression
    Cho, Hyoung-Soo
    Shin, Hyun Mu
    Haberstock-Debic, Helena
    Xing, Yan
    Owens, Timothy D.
    Funk, Jens Oliver
    Hill, Ronald J.
    Bradshaw, J. Michael
    Berg, Leslie J.
    JOURNAL OF IMMUNOLOGY, 2015, 195 (10): : 4822 - 4831
  • [3] A Covalent Inhibitor of ITK and RLK Inhibits Th1 and Th17 Cell Differentiation and Prevents Disease Manifestation in an Adoptive Transfer Model of Colitis
    Cho, Hyoung-Soo
    Conley, James
    Shin, Hyun Mu
    Haberstock-Debic, Helena
    Brameld, Kenneth A.
    Owens, Timothy D.
    Funk, Jens Oliver
    Hill, Ronald J.
    Bradshaw, Michael
    Berg, Leslie J.
    GASTROENTEROLOGY, 2015, 148 (04) : S27 - S27
  • [4] The oral ferroportin inhibitor vamifeport improves hemodynamics in a mouse model of sickle cell disease
    Nyffenegger, Naja
    Zennadi, Rahima
    Kalleda, Natarajaswamy
    Flace, Anna
    Ingoglia, Giada
    Buzzi, Raphael M.
    Doucerain, Cedric
    Buehler, Paul W.
    Schaer, Dominik J.
    Durrenberger, Franz
    Manolova, Vania
    BLOOD, 2022, 140 (07) : 769 - 781
  • [5] Role of Benzo (a) Pyrene in exacerbating the skin inflammation in Psoriatic mouse model
    Sharma, Swati
    Klein, Joshua
    Singh, Satyendra
    Goswami, Dinesh
    Braucher, Leah
    Wright, Holly
    Noland, Erica
    Agarwal, Rajesh
    Tewari-Singh, Neera
    FASEB JOURNAL, 2021, 35
  • [6] Kaempferol attenuates imiquimod-induced psoriatic skin inflammation in a mouse model
    Liu, C.
    Liu, H.
    Lu, C.
    Deng, J.
    Yan, Y.
    Chen, H.
    Wang, Y.
    Liang, C. -L.
    Wei, J.
    Han, L.
    Dai, Z.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2019, 198 (03): : 403 - 415
  • [7] Ingestion of Soybean Sprouts Containing a HASPIN Inhibitor Improves Condition in a Mouse Model of Alzheimer's Disease
    Tanaka, Hiromitsu
    Matsushita, Hiroaki
    Tokuhiro, Keizo
    Fukunari, Atsushi
    Ando, Yukio
    BIOLOGY-BASEL, 2023, 12 (02):
  • [8] Angiogenic psoriatic skin model
    Ayata, R. E.
    Auger, M.
    Pouliot, R.
    JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE, 2014, 8 : 194 - 195
  • [9] A novel mouse model for a blistering skin disease
    Hurskainen, T.
    Kokkonen, N.
    Jackow, J.
    Sormunen, R.
    Moilanen, J.
    Loffek, S.
    Soininen, R.
    Franzke, C. W.
    Bruckner-Tuderman, L.
    Tasanen, K.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2013, 133 : S21 - S21
  • [10] Glycerol Improves Skin Lesions in a Mouse Model of Psoriasis: Possible Mechanism
    Bollag, Wendy B.
    Choudhary, Vivek
    Uaratanawong, Rawipan
    Kaddour-Djebbar, Ismail
    Custer, Victoria
    Cohen, Elyssa
    Zhang, Catherine
    FASEB JOURNAL, 2019, 33